Microneedle-mediated intrascleral delivery of in situ forming thermoresponsive implants for sustained ocular drug delivery

Journal of Pharmacy and Pharmacology

Volumn 66, Issue 4, 2014, Pages 584-595

  Thakur, Raghu Raj Singh ^a   Fallows, Steven J ^a   McMillan, Hannah L ^a   Donnelly, Ryan F ^a   Jones, David S ^a  

^a QUEEN'S UNIVERSITY BELFAST   (United Kingdom)

Author keywords

microneedle; minimally invasive; optical coherence tomography; poloxamers; sclera

Indexed keywords

FLUORESCEIN SODIUM; POLOXAMER;

ANIMAL TISSUE; ARTICLE; DRUG DELIVERY SYSTEM; DRUG FORMULATION; DRUG RELEASE; EQUIPMENT DESIGN; EX VIVO STUDY; HEAT SENSITIVITY; MICRONEEDLE; MINIMALLY INVASIVE PROCEDURE; NONHUMAN; OPTICAL COHERENCE TOMOGRAPHY; ORTHOPEDIC THERAPEUTIC DEVICE; PHYSICAL PARAMETERS; SCLERA; SUSTAINED DRUG RELEASE; TEMPERATURE;

MICRONEEDLE; MINIMALLY INVASIVE; OPTICAL COHERENCE TOMOGRAPHY; POLOXAMERS; SCLERA;

ANIMALS; CHEMISTRY, PHARMACEUTICAL; DELAYED-ACTION PREPARATIONS; DRUG ADMINISTRATION ROUTES; DRUG DELIVERY SYSTEMS; FLUORESCEIN; MICROINJECTIONS; NEEDLES; POLOXAMER; PROSTHESES AND IMPLANTS; RABBITS; RHEOLOGY; SCLERA;

EID: 84899068318     PISSN: 00223573     EISSN: 20427158     Source Type: Journal    
DOI: 10.1111/jphp.12152     Document Type: Article

References (35)

1. Ghate D, Edelhauser HF,. Ocular drug delivery. Expert Opin Drug Deliv 2006; 2: 275-287.
2. Del Amo EM, Urtti A,. Current and future ophthalmic drug delivery systems. A shift to the posterior segment. Drug Discov Today 2008; 3-4: 135-143.
3. Peyman NGA, etal. Intravitreal injection of therapeutic agents. Retina 2009; 7: 875-912.
4. Janoria KG, etal. Novel approaches to retinal drug delivery. Expert Opin Drug Deliv 2007; 4: 371-388.
5. Fatt I, Weissman BA,. Physiology of the Eye: An Introduction to the Vegetative Functions, 2nd edn. Boston, MA: Butterworth-Heinemann, 1992.
6. Prausnitz MR, Noonan JS,. Permeability of cornea, sclera, and conjunctiva: a literature analysis for drug delivery to the eye. J Pharm Sci 1998; 12: 1479-1488.
7. Okabe J, etal. Biodegradable intrascleral implant for sustained intraocular delivery of betamethasone phosphate. Invest Ophthalmol Vis Sci 2003; 2: 740-744.
8. Olsen TW, etal. Cannulation of the suprachoroidal space: a novel drug delivery methodology to the posterior segment. Am J Ophthalmol 2006; 5: 777-787. e2.
9. Gomes Dos Santos AL, etal. Sustained release of nanosized complexes of polyethylenimine and anti-TGF-beta 2 oligonucleotide improves the outcome of glaucoma surgery. J Control Release 2006; 3: 369-381.
10. Ambati J, etal. Transscleral delivery of bioactive protein to the choroid and retina. Invest Ophthalmol Vis Sci 2000; 5: 1186-1191.
11. Davies JB, etal. Delivery of several forms of DNA, DNA-RNA hybrids, and dyes across human sclera by electrical fields. Mol Vis 2003; 15: 569-578.
12. Ambati J, etal. Diffusion of high molecular weight compounds through sclera. Invest Ophthalmol Vis Sci 2000; 5: 1181-1185.
13. Thrimawithana TR, etal. Drug delivery to the posterior segment of the eye. Drug Discov Today 2011; 16: 270-277.
14. Yasukawa T, etal. Biodegradable scleral plugs for vitreoretinal drug delivery. Adv Drug Deliv Rev 2001; 52: 25-36.
15. Okabe J, etal. Biodegradable intrascleral implant for sustained intraocular delivery of betamethasone phosphate. Invest Ophthalmol Vis Sci 2003; 44: 740-744.
16. Peng YJ, etal. Solvent-free biodegradable scleral plugs providing sustained release of vancomycin, amikacin, and dexamethasone-an in vivo study. J Biomed Mater Res A 2010; 94: 426-432.
17. Donnelly RF, etal. Microneedle-Mediated Transdermal and Intradermal Drug Delivery. Oxford: Wiley-Blackwell, 2012.
18. Gilger BC, etal. Treatment of acute posterior uveitis in a porcine model by injection of triamcinolone acetonide into the suprachoroidal space using microneedles. Invest Ophthalmol Vis Sci 2013; 54: 2483-2492.
19. Jiang J, etal. Intrascleral drug delivery to the eye using hollow microneedles. Pharm Res 2008; 26: 395-403.
20. Jones DS, etal. Solute and solvent effects on the thermorheological properties of poly(oxyethylene)-poly(oxypropylene) block copolymers: implications for pharmaceutical dosage form design. J Appl Polym Sci 2003; 6: 1016-1026.
21. Rajoria G, Gupta A,. In-situ gelling system: a novel approach for ocular drug delivery. AJPTR 2012; 4: 24-53.
22. Merck. Sterile ophthalmic gel-forming solution Timoptic-XE. 2003.
23. Colin J, etal. Ganciclovir ophthalmic gel (Virgan; 0.15%) in the treatment of herpes simplex keratitis. Cornea 1997; 4: 393-399.
24. Alexandridis P, Alan Hatton T,. Poly(ethylene oxide)-poly(propylene oxide)-poly(ethylene oxide) block copolymer surfactants in aqueous solutions and at interfaces: thermodynamics, structure, dynamics, and modeling. Colloids Surf A Physicochem Eng Asp 1995; 1-2: 1-46.
25. Miller SC, Drabik BR,. Rheological properties of poloxamer vehicles. Int J Pharm 1984; 18: 269-276.
26. Schmolka IR,. Physical basis for poloxamer interactions. Ann N Y Acad Sci 1994; 1: 92-97.
27. Wei G, etal. Thermosetting gels with modulated gelation temperature for ophthalmic use: the rheological and gamma scintigraphic studies. J Control Release 2002; 1: 65-74.
28. Edsman K, etal. Rheological evaluation of poloxamer as an in situ gel for ophthalmic use. Eur J Pharm Sci 1998; 2: 105-112.
29. Gratieri T, etal. Enhancing and sustaining the topical ocular delivery of fluconazole using chitosan solution and poloxamer/chitosan in situ forming gel. Eur J Pharm Biopharm 2011; 2: 320-327.
30. Nanjwade BK, etal. Formulation and evaluation of micro hydrogel of Moxifloxacin hydrochloride. Eur J Drug Metab Pharmacokinet 2012; 2: 117-123.
31. Kalam MA, etal. Preparation, characterization, and evaluation of gatifloxacin loaded solid lipid nanoparticles as colloidal ocular drug delivery system. J Drug Target 2010; 3: 191-204.
32. Rifkin L, Schaal S,. Factors affecting patients' pain intensity during in office intravitreal injection procedure. Retina 2012; 32: 696-700.
33. Mogensen M, etal. Optical coherence tomography for imaging of skin and skin diseases. Semin Cutan Med Surg 2009; 3: 196-202.
34. Fercher AF,. Optical coherence tomography-development, principles, applications. Z Med Phys 2010; 4: 251-276.
35. Ghosn MG, etal. Nondestructive quantification of analyte diffusion in cornea and sclera using optical coherence tomography. Invest Ophthalmol Vis Sci 2007; 6: 2726-2733.